TEST:

MiCheck® Prostate

MiCheck® Prostate is a blood test that uses our patented algorithm together with other biomarkers to estimate the risk of a patient having aggressive prostate cancer. MiCheck® Prostate is designed to assist urologists in making the decision to recommend a patient for a biopsy or to recommend some form of active surveillance monitoring. MiCheck® Prostate can assist urologists in making the decision to refer a patient to biopsy by estimating the risk of the patient having aggressive prostate cancer. MiCheck® Prostate is a simple blood test that provides an answer to the physician on the patient’s cancer risk within 48 hours.